The 16th Pharmaceutical Compliance Congress and Best Practices Forum kicks off Wednesday and the PharmaCertify™ team is looking forward to a variety of speakers and sessions. Here are just a few at the top of our list:
Day One Plenary Sessions – FBI’s New Focus on FCPA
Having someone from the FBI discuss its perspective on FCPA enforcement and investigations should prove to be an interesting twist, particularly in regard to cases of corporate wrongdoing.
Day Two Morning Plenary Sessions – CMS Update
Doug Brown typically offers compelling metrics regarding Open Payments and we expect more of the same this week. We’re also interested in hearing about the agency’s progress with improvements to Open Payments, and the guidance Mr. Brown has to share regarding the rule changes, which go into effect in 2016.
Day Two Mini Summits – I and IX
Mini Summit I deals with speaker programs. Enforcement agencies continue to point to speaker payments and programs as an avenue for illegal remuneration to healthcare professionals. Hopefully, panelists will share best practices for building a compliant speakers bureau. Mini Summit IX is a somewhat similar topic, but it covers healthcare professional meetings and global transparency. There are myriad laws and codes that can come into play from just one meeting. Hearing how the panelists managing these varying requirements should be helpful.
Day Two Closing Plenary Session – Millennials and the Future of Ethics and Compliance Programs: New Technologies and Eternal Issues
As the number of millennials in the workforce grows, compliance professionals need to learn effective techniques for integrating ethics messages. Have the tools changed? Are we providing compelling information and messages?
Stop by and see us at the conference!
If you’re attending the conference, don’t forget to stop by Booth 204 to see our newest compliance training and communication solutions, including TOVdisclosure.com™, a streamlined and intuitive tool for sharing TOV information with HCPs, before it’s submitted for publication.
Stay compliant and we’ll see you in Washington!